百龙创园 20260227 摘要 2025 年膳食纤维总销量超 4.8 万吨，其中聚葡萄糖约 2.1 万吨，抗性 糊精约 2.7 万吨。抗性糊精销量同比增长接近 50%，聚葡萄糖因产能受 限同比下降约 20%。产品结构调整是聚葡萄糖销量下滑主因，并非需求 端走弱。 2025 年阿洛酮糖成交量略高于 1 万吨，同比增长不到 30%，单价同比 下降 10%-20%，主要受上游原料价格影响。但受益于新产线投用和原 料向上游延伸，阿洛酮糖毛利率仍提升不到 10 个百分点。 阿洛酮糖相关酶制剂已获批，产品预计 3 月底前落地。预计 2026 年对 收入和利润有贡献，但具体规模不确定。饮品端或率先导入阿洛酮糖， 因国内无糖饮品市场体量更大，且易实现不含糖。 公司预计阿洛酮糖销量中期增速可维持在 20%-30%甚至更高。当前全 球用量约 3 万吨，未来市场空间大。价格是主要制约因素，需健康意识 提升、下游厂商推动和消费者教育。 新增 2-3 万吨膳食纤维产能项目已进入调试投产阶段，预计二季度开始 贡献收入和利润，四季度左右可能满产。产品结构将根据市场需求决定， 若抗性糊精需求增长快，其增速可能显著快于聚葡萄糖。 Q&A 外 ...

格隆汇2月26日｜A股代糖概念股短线拉升，其中，保龄宝封涨停板，三元生物、金禾实业、华康股份 等跟涨。 ...

过去几年，芬兰人靠着树皮发家，日本人凭着技术定价，而中国河南安阳一出手，就把全局翻了盘。谁 都没想到，一个靠玉米芯发电、做锅炉料的地方，能用这堆"废料"搅了全球代糖市场的局——几千块一 吨卖出的木糖醇，如今直接干到白菜价，简直是"穷人靠抠，富人靠价，安阳靠脑袋"的真实写照。这不 是工业小聪明，这是赤裸裸的产业降维打击。 这几年自主研发投入加大，几家当地龙头企业合作联动科研团队，把从玉米芯中提取木糖醇的整套流程 做到了极致。比如在水解与脱色这两个最费能耗的环节优化出工艺稳定模式，同时引入清洁能源原料 链，一系列改造之后，最终把成本狠狠砍了一刀。 2025年的数据让人侧目，安阳本地数十家企业单年产能突破10万吨，最低出厂价格跑到了2.1万元/吨以 下。这不是降价促销，是技术压倒性优势下的正常出价。而这还只是起点，背后还有禹城、衡水等一批 新兴区域在跟进。 要说木糖醇这东西，最早确实不是中国的"配方"。发明它的，是北欧人，种得不是甜菜，是财富密码。 特别是芬兰，地广林多，白桦树比人还容易聚集人口。几十年前，丹尼斯克这样的传统巨头就把木糖醇 商业化，从白桦树皮里提取出来，既能防蛀牙，还不升血糖，迅速成为高端食品工业里 ...

Core Viewpoint - The article discusses the potential of D-Allulose as a sugar substitute, highlighting its approval as a new food ingredient and the subsequent market dynamics, including production capacity expansion and challenges in consumer market adoption [6][10][42]. Group 1: D-Allulose Overview - D-Allulose is a natural sugar found in fruits and plants, with a sweetness level about 70% that of sucrose and only 10% of the calories [8][42]. - It was officially approved as a new food ingredient by the National Health Commission on July 2, 2025, leading to a surge in market interest and stock prices of related companies [10][11]. Group 2: Production and Market Dynamics - Following the approval, companies like Microgen and COFCO announced their production capabilities, with several firms rapidly expanding their production capacity [17][20]. - By September 2025, multiple companies had reported significant production capacity plans, with some targeting annual outputs of up to 30,000 tons [21][22]. Group 3: Consumer Market Challenges - Despite the production enthusiasm, the consumer market remains relatively quiet, with only a few products, such as those from Nayuki Tea and Yoyi C, publicly utilizing D-Allulose [11][24]. - The slow adoption in the consumer market is attributed to internal project timelines within companies and the need for product development before market launch [28][31]. Group 4: Cost and Production Challenges - The cost of D-Allulose remains a significant barrier, with prices ranging from 20,000 to 24,000 yuan per ton, compared to traditional sugars like sucrose at around 6,000 yuan per ton [33][36]. - The production methods for D-Allulose, including fermentation and enzymatic conversion, present technical challenges that contribute to higher costs [37][40]. Group 5: Application Potential - D-Allulose is expected to find its initial applications in high-end markets where price sensitivity is lower, rather than as a direct substitute for sucrose in mainstream products [44][46]. - Its classification as a food ingredient rather than an additive allows for broader applications across various food categories, including baking and dairy products [48][49].

Core Viewpoint - The sugar substitute stock, Bailong Chuangyuan (605016.SH), experienced a surge in share price following the announcement of a significant profit increase, driven by the approval and application of allulose sugar in China [2][3]. Group 1: Company Performance - Bailong Chuangyuan reported a revenue of 1.38 billion yuan for 2025, marking a year-on-year increase of 19.8% [2]. - The company's net profit attributable to shareholders reached 370 million yuan, reflecting a substantial growth of 48.9% year-on-year [2]. - The growth in performance is attributed to an optimized product structure, with a higher sales proportion of high-margin resistant dextrin products, as well as cost reductions from technological upgrades and improved capacity utilization [2]. Group 2: Market Trends and Product Development - The market is increasingly focused on the development prospects of allulose sugar, with multiple institutions monitoring Bailong Chuangyuan's positioning in this sector [2]. - The company has established a production capacity of 15,000 tons of crystalline allulose sugar and plans to launch a new food raw material factory in Thailand by 2026, which will add 12,000 tons of crystalline allulose sugar and 7,000 tons of liquid D-allulose sugar capacity [3]. - Allulose sugar has been officially approved as a new food raw material in China, with its demand projected to reach between 150,000 to 200,000 tons in the next 3-5 years [3]. Group 3: Competitive Landscape - Despite the promising outlook for allulose sugar, its cost remains significantly higher than that of erythritol, which has hindered large-scale application [4]. - The past two years have seen a decline in the performance growth of other sugar substitute companies due to the chaotic expansion of erythritol production, leading to a drop in raw material prices [4]. - Major sugar substitute companies, including Baolingbao and Sanyuan Biological, are now focusing on allulose sugar to regain market momentum [4].

Core Viewpoint - The article highlights the significant growth of the sugar substitute stock, Bailong Chuangyuan (605016.SH), following the approval and application of allulose sugar in China, with a reported 48.9% increase in net profit for 2025 [3][5]. Group 1: Company Performance - Bailong Chuangyuan reported a revenue of 1.38 billion yuan for 2025, marking a year-on-year increase of 19.8% [3]. - The company's net profit attributable to shareholders reached 370 million yuan, reflecting a 48.9% year-on-year growth [3]. - The growth is attributed to an optimized product structure, with a higher sales proportion of high-margin resistant dextrin products, and cost reductions from technological upgrades [3][5]. Group 2: Market Trends and Product Development - The approval of allulose sugar as a new food ingredient in China is expected to drive demand, with projections estimating a domestic demand of 150,000 to 200,000 tons over the next 3-5 years [5]. - Major food and beverage companies, such as Mengniu, are accelerating the application of allulose sugar in their products, with some already testing allulose sugar formulations [5]. - Despite the high cost of allulose sugar compared to erythritol, which is 2-3 times higher, improvements in extraction efficiency are anticipated to gradually lower costs [6]. Group 3: Industry Challenges - The past two years have seen a slowdown in the performance of sugar substitute companies due to the chaotic expansion of erythritol production, leading to a drop in raw material prices [5]. - Companies like San Yuan Biological and Baolingbao are now focusing on allulose sugar to regain market momentum [5].

Group 1 - The core viewpoint of the news is the significant growth in the performance of sugar substitute company Bailong Chuangyuan, with a 48.9% increase in net profit for 2025, driven by the approval and application of allulose sugar in China [1] - Bailong Chuangyuan reported a revenue of 1.38 billion yuan for 2025, representing a year-on-year growth of 19.8%, and a net profit of 370 million yuan, reflecting a 48.9% increase compared to the previous year [1] - The company's performance growth is attributed to an optimized product structure, with a higher sales proportion of high-margin resistant dextrin products, as well as cost reductions from technological upgrades and improved capacity utilization [1] Group 2 - The National Health Commission of China officially approved allulose sugar as a new food raw material in July 2025, which is expected to have a demand of 150,000 to 200,000 tons in the domestic market over the next 3-5 years [2] - Following the approval, food and beverage companies in China are accelerating the application of allulose sugar in their products, with brands like Mengniu's Youyi C zero-sugar series being the first to adopt this ingredient on a large scale [2] - Despite the high cost of allulose sugar compared to erythritol, which is 2-3 times higher, several major sugar substitute companies are expanding their production or planning to enter the allulose sugar market to regain competitive advantage [2][3] Group 3 - Current market prices for allulose sugar range from 28,000 to 30,000 yuan per ton, while erythritol is priced between 9,000 and 10,000 yuan per ton, indicating a significant cost disparity [3] - Improvements in technology have led to enhanced conversion and extraction efficiency for allulose sugar, resulting in a decrease in its price, although it remains high compared to erythritol [3] - The market performance of allulose sugar post-launch is still uncertain, as its higher production costs may impact its widespread adoption [3]

Core Viewpoint - The A-share market is experiencing an upward trend, driven by sectors such as pharmaceuticals, media, and non-bank financials, with significant gains in online consumption ETFs and leading companies in the consumer goods sector [1] Group 1: Market Performance - As of 13:50, the online consumption ETF (159728.SZ) rose by 4.35%, with BlueFocus up 19.97%, Tianxiashow up 10%, and 37 Interactive Entertainment up 10% [1] - The consumer goods sector is seeing robust growth due to category innovation and new channel expansion strategies [1] Group 2: Policy Support - The government is promoting consumption recovery through the "Special Action Plan to Boost Consumption," focusing on increasing residents' income, promoting bulk consumption, and fostering new consumption types [1] - The "14th Five-Year Plan" emphasizes consumption as a key driver of economic growth, indicating ongoing policy support [1] Group 3: Industry Trends - Traditional consumer categories are approaching a fundamental recovery point, supported by both policy catalysts and improving macroeconomic indicators [1] - The online retail sector is evolving towards precision and digitalization, with market vitality expected to continue being released under the influence of both incremental and stock policies [1] Group 4: Investment Opportunities - The online consumption ETF (159728.SZ) is positioned to benefit from the steady growth of online retail and the continuous release of policy dividends, presenting good allocation value [1]

Core Insights - The company has received approval for its allulose as the first new food ingredient in China, with several leading food and beverage companies expected to launch new products using allulose by the end of December 2025 [1][3] - The company's enzymatic production of allulose is based on "independent core technology + industry chain synergy," which provides a competitive edge in terms of high enzyme conversion rates and lower costs due to internal supply of raw materials [1][4] - The market for new sweeteners is driven by "health consumption upgrades," with future trends expected to show "total expansion, structural upgrades, and scene segmentation" [2][5] Company Developments - The company is promoting 375g and 250g packaging of allulose products on various e-commerce platforms, including Douyin, Taobao, Xiaohongshu, and others [1][3] - The company plans to continuously optimize its processes and expand production capacity to maintain its leading position in the health sweetener market [4][5] - The product matrix and core product adjustments will align with industry trends, focusing on "core technology + industry chain synergy" to build differentiated competitiveness [2][5]

Group 1: Investor Relations Activity - The investor relations activity involved a concentrated exchange event organized by COFCO Group, attended by various investment institutions and analysts [1] - The meeting took place on December 18, 2025, from 14:00 to 16:30 at COFCO Fulinmen Building [1] Group 2: Product Development and Market Strategy - COFCO Biotechnology has received approval for its alulose as the first new food ingredient in China, with multiple leading food and beverage companies currently testing samples [1] - It is expected that by the end of December 2025, several major companies will launch new products using alulose as an ingredient [1] - The company is promoting 375g and 250g small packaging products on various e-commerce platforms [1] Group 3: Production Technology and Cost Efficiency - The company claims a competitive edge in the enzymatic production of alulose due to its proprietary core technology and industry chain synergy, leading to high conversion rates and lower costs [2] - The internal supply of raw materials, specifically fructose, allows for stable and cost-effective production compared to competitors who need to purchase fructose externally [2] - The company plans to continue optimizing processes and expanding capacity to maintain its leading position in the healthy sweetener market [2] Group 4: Future Market Outlook - The launch of new sweeteners is driven by a trend towards "healthier consumption," with expectations of market expansion and structural upgrades in the food and beverage sector [2] - The company aims to adjust its product matrix and core product structure in response to market trends, focusing on technology and industry chain advantages to build differentiated competitiveness [2] - Future strategies will include consolidating existing market shares and targeting high-end sweetener segments [2]